Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2013 Sep 3;139(10):10.1007/s00432-013-1501-6. doi: 10.1007/s00432-013-1501-6

Table 2. High frequency ovarian cancer autoantibody targets.

High frequency autoantibody targets identified by top-down proteomics microarray screening and iTRAQ quantitative proteomics analysis. (A) Autoantibodies found in ovarian cancer as compared to benign ovarian disease and age matched healthy female samples. (B) Autoantibodies that were significantly higher in stage I cancer samples as compared to stage II-IV samples.

2A. OVCA Specific as compared to benign and normal
Protein Name Symbol Uniprot P-Value
Cofilin-1 CFL1 P23528 0.095925132
Ezrin EZR P15311 0.086806974
HistoneH1.2 HIST1H1C P16403 0.034922637
Heterogeneous nuclear ribonucleoprotein A/B HNRNPAB Q99729 0.079023531
Stress-70 protein, mitochondrial HSPA9 P38646 0.00865349
PDZ domain-containing protein 11 PDZD11 Q5EBL8 0.000796403
Profilin-1 PFN1 P07737 0.000864174
Peptidyl-prolyl cis-1rans isomer ase A PPIA P62937 0.000187017
Small EDRK-rich factor 2 SERF2 P84101 0.043832054
Tubulin alpha-1C chain TUBA1C Q9BQE3 0.001168379
Junction plakoglobin JUP P14923 0.051950189
2B. OVCA stage I specific as compared to stage II-IV
Protein Name Symbol Uniprot P-Value
Cofilin-1 CFL1 P23528 0.042964969
Ezrin EZR P15311 0.040955999
HistoneH1.2 HIST1H1C P16403 0.002287586
Heat schock-related 70 kDa protein 2 HSPA2 P54652 0.000998804
PDZ domain-containing protein 11 PDZD11 Q5EBL8 0.042129066
Tubulin alpha-1C chain TUBA1C Q9BQE3 0.01001449
Junction plakoglobin JUP P14923 0.067963873